Childress Capital Advisors, LLC Moderna, Inc. Transaction History

Childress Capital Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$118.38 - $210.04 $139,214 - $247,007	1,176 New	1,176 $211,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $147,232 - $221,973	-1,257 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$126.46 - $235.05 $36,167 - $67,224	286 Added 29.45%	1,257 $217,000
Q4 2021 Jan 26, 2022	BUY	$225.82 - $368.51 $3,838 - $6,264	17 Added 1.78%	971 $247,000
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $13,535 - $29,552	61 Added 6.83%	954 $372,000
Q2 2021 Jul 28, 2021	BUY	$129.91 - $234.98 $116,009 - $209,837	893 New	893 $209,000
Q1 2021 May 21, 2021	SELL	$109.18 - $185.98 $16,158 - $27,525	-148 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$65.74 - $169.86 $9,729 - $25,139	148 New	148 $15,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Childress Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Childress Capital Advisors, LLC with notifications on news.